Tuberculosis is said to be one of the oldest and contagious disease across the world. Approximately 1.4m people have to lose their lives die to the same. However, a research, which has been published in the Journal Lancet, has raised hopes for people, who are at risk of getting infected from TB.

The research has been taken led by a group of researchers from Stellenbosch University, South Africa. They were of the view that the three drugs, which they have developed has potential of killing more than 99% of the bacteria and that too in just two weeks. The three drugs used to combat TB were pyrazinamide, PA-824 and moxifloxcin.

Lead author Andreas Diacon said, "The results of this study give healthcare providers on the front-lines of the TB epidemic hope for better, faster tools needed to stop this disease".

Seeing the results of the drug, Mario Raviglione, who is a TB expert with the World Health Organization, has raised hopes that the drug may be able to reduce the number.

Clinical trials have showed that the drug will more effective than other existing drugs. Further clinical trial will be conducted, said researchers. Mario said that if further clinical trials gave the same results then they will be having something strong in their hand to combat TB.